Abstract
Among thyroid carcinomas, thyroglobulin is a good tumor marker for differentiated carcinoma (papillary carcinoma, follicular carcinoma). In particular, it is widely used for monitoring of patients with total or near-total thyroidectomy. On the other hand, medullary thyroid caricima has a very sensitive and specific tumor marker, calcitonin. In inherited medullary carcinoma (multiple endocrine neoplasia type 2), RET protooncogene analysis is the best for detecting early medullary thyroid carcinoma.
MeSH terms
-
Adenocarcinoma, Follicular / diagnosis
-
Biomarkers, Tumor / blood*
-
Calcitonin / blood*
-
Carcinoembryonic Antigen / blood
-
Carcinoma, Medullary / diagnosis
-
Carcinoma, Papillary / diagnosis
-
Enzyme-Linked Immunosorbent Assay
-
Humans
-
Immunoradiometric Assay
-
Multiple Endocrine Neoplasia Type 2b / diagnosis
-
Multiple Endocrine Neoplasia Type 2b / genetics
-
Proto-Oncogene Proteins / genetics*
-
Proto-Oncogene Proteins c-ret
-
Receptor Protein-Tyrosine Kinases / genetics*
-
Thyroglobulin / blood*
-
Thyroid Neoplasms / diagnosis*
-
Thyroidectomy
Substances
-
Biomarkers, Tumor
-
Carcinoembryonic Antigen
-
Proto-Oncogene Proteins
-
Calcitonin
-
Thyroglobulin
-
Proto-Oncogene Proteins c-ret
-
Receptor Protein-Tyrosine Kinases